PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy

Overview of attention for article published in Frontiers in immunology, June 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 16 followers.

Revolutionize T-cell immunotherapy with PHE1-based bispecific antibodies targeting multiple antigens for cancer treatment. #InnovationInBiomedicine https://t.co/Hm1SnAhAyk | Follow @biomedhack for #biohacking news to help you live healthier and longer. htt

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.